(Q41014953)

25 September 2017

title

IL-4 inhibits P-glycoprotein in normal and malignant NK cells (English)

1 reference

25 September 2017

Tambur AR

1

1 reference

25 September 2017

Markham PN

series ordinal

2

1 reference

25 September 2017

Gebel HM

series ordinal

3

1 reference

25 September 2017

publication date

1 August 1998

1 reference

25 September 2017

1 reference

25 September 2017

volume

59

1 reference

25 September 2017

issue

8

1 reference

25 September 2017

page(s)

483-487

1 reference

Genetic mechanisms of tumor suppression by the human p53 gene

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900042-1

7 January 2021

Cancer gene therapy using a novel adeno-associated virus vector expressing human wild-type p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900042-1

7 January 2021

A model for p53-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900042-1

7 January 2021

Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900042-1

7 January 2021

Inactivation of Bcl-2 by phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900042-1

7 January 2021

Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900042-1

7 January 2021

Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammals

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900042-1

7 January 2021

The biochemistry of P-glycoprotein-mediated multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900042-1

7 January 2021

Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900042-1

7 January 2021

Aggressive natural killer cell lymphoma/leukemia. A recently recognized clinicopathologic entity.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900042-1

7 January 2021

Aggressive natural killer (NK) cell lymphoma: report of a pediatric case and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900042-1

7 January 2021

Multidrug resistance activity in human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900042-1

7 January 2021

Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900042-1

7 January 2021

Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900042-1

7 January 2021

Oligonucleotide modulation of multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900042-1

7 January 2021

Interleukin 4 counteracts the interleukin 2-induced proliferation of monoclonal B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900042-1

7 January 2021

A phase I trial of continuous infusion interleukin-4 (IL-4) alone and following interleukin-2 (IL-2) in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900042-1

7 January 2021

10.1016/S0198-8859(98)00042-1

Identifiers

DOI

1 reference

25 September 2017

1 reference